GGrantIndex
← Leaderboards

Anthony John Griswold

University Of Miami School Of Medicine

$12,295,725
Attributed
$43,108,297
Total exposure
8
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $13.8M · FY202125
$20M$15M$10M$5M$0
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$43,108,297 · 8

By mechanism

U01$35,516,842 · 3
U19$3,020,431 · 1
RF1$2,290,195 · 1
R01$1,494,418 · 1
R21$786,411 · 2

Most similar at University Of Miami School Of Medicine

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Alzheimer&Apos

Research focus

Alzheimer&AposSamplingS DiseaseResourcesCohortS Disease RiskAfrican AmericanPathway InteractionsGeneticData SetGenomicsGenotypeCommunitiesGenome-WidePlasmaBiological MarkersAfricanGenesPopulation HeterogeneityMolecularAlzheimer’S Disease BiomarkerNot Hispanic Or LatinoWhole BloodArchitecture

Grant awards (21)

Characterizing the Genetic Risk for Alzheimer Disease in African and Admixed African-American Ancestries$3,895,266
U01 · FY2025 · AG · contact PI
Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease$1,354,054
U01 · FY2025 · AG
Genomic, Epigenomic, and Transcriptomic Mechanisms of Contributing to Alzheimer's Disease Risk in Diverse Ancestral Populations$726,518
R01 · FY2025 · AG · contact PI
Core D: Genomics and Biomarker Core$682,254
U19 · FY2025 · AG · contact PI
Characterizing the Genetic Risk for Alzheimer Disease in African and Admixed African-American Ancestries$86,462
U01 · FY2025 · AG · contact PI
Additional Sequencing for the Alzheimer Disease Sequencing Project (ADSP) the Follow-Up Study (FUS), The Diverse Population Initiative$6,545,108
U01 · FY2024 · AG
Characterizing the Genetic Risk for Alzheimer Disease in African and Admixed African-American Ancestries$4,050,927
U01 · FY2024 · AG · contact PI
Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease$1,381,687
U01 · FY2024 · AG
Core D: Genomics and Biomarker Core$901,942
U19 · FY2024 · AG · contact PI
Genomic, Epigenomic, and Transcriptomic Mechanisms of Contributing to Alzheimer's Disease Risk in Diverse Ancestral Populations$767,900
R01 · FY2024 · AG · contact PI
Extracellular RNA Expression Biomarkers in Osteoarthritis Disease and Progression$163,785
R21 · FY2024 · AR · contact PI
Additional Sequencing for the Alzheimer Disease Sequencing Project (ADSP) the Follow-Up Study (FUS), The Diverse Population Initiative$6,942,173
U01 · FY2023 · AG
Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease$1,380,880
U01 · FY2023 · AG
Core D: Genomics and Biomarker Core$801,009
U19 · FY2023 · AG · contact PI
Investigating Genomic Instability and Loss of the Y Chromosome in Alzheimer’s Disease$422,125
R21 · FY2023 · AG
Extracellular RNA Expression Biomarkers in Osteoarthritis Disease and Progression$200,501
R21 · FY2023 · AR · contact PI
Additional Sequencing for the Alzheimer Disease Sequencing Project (ADSP) the Follow-Up Study (FUS), The Diverse Population Initiative$7,088,448
U01 · FY2022 · AG
Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease$1,381,688
U01 · FY2022 · AG
Core D: Genomics and Biomarker Core$635,226
U19 · FY2022 · AG · contact PI
Genomic, Epigenomic, and Transcriptomic Mechanisms of Contributing to Alzheimer's Disease Risk in Diverse Ancestral Populations$2,290,195
RF1 · FY2021 · AG · contact PI
Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease$1,410,149
U01 · FY2021 · AG